Mavacamten and the Reframing of Obstructive Hypertrophic Cardiomyopathy as a Medically Treatable Disease. (2022). Journal of Heart and Cardiovascular Science, 3(1), 16-21. https://doi.org/10.5281/zenodo.22344598